DNA Drug Trials Genomics Protein 
Drug Discovery World
JANUARY 17, 2024
ctDNA is fragmented DNA released from dead or dying cancer cells, through the process of apoptosis or necrosis. ctDNA carries fragments of genomic information, whereas CTCs carry whole sequences, facilitating not only genomic, but transcriptomic and proteomic analysis. 21 In a recent publication, Silvestri et al.,
Drug Discovery World
OCTOBER 6, 2022
Jarret Glasscock , PhD, CEO of Cofactor Genomics explains how diagnostics are emerging as the key to ensuring the right patients get matched to the right therapy, at the right time. . In the cancer space alone over the last five years, clinical trials have increased 500% for new drugs and new drug combinations.
Expert insights. Personalized for you.
59 
Let's personalize your content